Iantech

About:

Iantech is a developer of a cataract treatment device.

Website: http://iantechmed.com/

Top Investors: Visionary Venture Fund, Global Health Investment Fund (GHIF)

Description:

Iantech has developed advanced micro-­interventional technology for cataract surgery. After 50 years of conventional phacoemulsification, Iantech introduces a micro-­interventional technique designed to deliver energy-­free endocapsular lens fragmentation, giving surgeons control, efficiency and new opportunities to improve their surgical technique. At Iantech, They are working to invent new surgical approaches which can reduce the global footprint of cataract blindness. Using smart, efficient and adaptable micro-­interventional technology, Their team is building a new surgical platform to catalyze global outreach efforts as we fight the 25M blindness epidemic in the world

Total Funding Amount:

$8.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Reno, Nevada, United States

Founded Date:

2013-01-01

Contact Email:

admin(AT)iantechmed.com

Founders:

Luke Clauson

Number of Employees:

1-10

Last Funding Date:

2017-07-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai